Checked.be · Company dossierhttps://checked.be/en/c/pharmony-0830310102 · as of 20-11-2026
PHARMONY
ActivePrivate limited company · founded 2010 · active for 16 yearsAvenue d'Ecolys 2, 5020 NamurKBO/BCE: BE 0830.310.102subsidiary of Hidden nameVisible after signing in
Save to list
Keep companies in your own lists to find and compare them later. All it takes is a free account.
Lower solvency than 95% of companies in head offices and management consultancy. The sector median is 52.0%, over 10,662 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 6,922 companies had the same profile as PHARMONY has now. Each dot stands for 18 companies, two years later.
85.3%
were still trading
8.3%
stopped another way
5.8%
went bankrupt
Micro
10 to 20 years old
negative equity
a loss of 10% of the balance sheet or more
Another 0.6% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,922 companies, not a prediction for PHARMONY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Name hiddenVisible after signing in resigns as director
General meeting of 13-03-2023 · Gazette deed
Hidden nameVisible after signing in resigns as directorName after signing inVisible after signing in appointed as director · General meeting of 25-06-2021 · Gazette deed
Name hiddenVisible after signing in changes role from manager to directorHidden nameVisible after signing in appointed as director · Discharge granted to Name after signing inVisible after signing in · General meeting of 14-09-2020 · Gazette deed
Registered office moved from Evere to Namur
The registered office moved from Avenue du Frioul, 36 bte 41-B-1140 Evere to Avenue Ecolys, 2-5020 Namur (Suarlée) · Name hiddenVisible after signing in resigns as manager · Hidden nameVisible after signing in acts as permanent representative · General meeting of 27-12-2018 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as PHARMONY: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €244,000 and €390,000, founded between 2006 and 2010.
Official details
Source: KBO
Status
Active since 15-10-2010Normal situation
Registered office
92 active companies are registered at this addressOf these, 4 started in the 12 months before 20 November 2026. Source: KBO register, as of 20 November 2026.
The company number of PHARMONY is 0830.310.102. The VAT number is the same number with BE in front: BE 0830.310.102.
Where is PHARMONY based?
The registered office is at Avenue d'Ecolys 2, 5020 Namur.Company details
What does PHARMONY do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of PHARMONY?
PHARMONY is a private limited company (BV).
When was PHARMONY founded?
PHARMONY was founded on 15-10-2010.
Is PHARMONY still active?
Yes, PHARMONY is an active enterprise in the KBO register.
How many employees does PHARMONY have?
PHARMONY had an average of 8.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMONY?
The turnover in financial year 2025 is about €700,000. This figure is estimated from the gross margin of €460,000 and 72 comparable companies (NACE 70200). It probably lies between €540,000 and €1.3m.
Is PHARMONY profitable?
In financial year 2025, PHARMONY made a loss of €255,925.
Where can I find the annual accounts of PHARMONY?
PHARMONY filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMONY due?
PHARMONY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline